Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis

doi:10.4251/wjgo.v12.i1.66

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7254)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

460

WORD

292

HTML

3747

Figures (1-2)

513

Tables (1-2)

234

Sum=5246

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

751

Download

1257

Sum=2008

Jan 15, 2020 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Jan 15, 2020; 12(1): 66-76
Published online Jan 15, 2020. doi: 10.4251/wjgo.v12.i1.66

Table 1 Dynamic alterations of liver or serum CD44 and alpha-fetoprotein at protein level in rat hepatocarcinogenesis

Group	n	Liver CD44, ng/per mg liver	Serum CD44, ng/mL	Liver AFP, ng/per mg liver	Serum AFP, ng/mL
Control	12	1.465 ± 0.341	9.193 ± 1.176	1.757 ± 0.452	0.881 ± 0.092
NAFLD	24	1.920 ± 0.311^a	10.432 ± 2.288	2.185 ± 0.553	0.958 ± 0.131
Denaturation	17	1.830 ± 0.460^a	19.913 ± 7.277^a	3.023 ± 0.797^a	1.460 ± 0.394^a
Precancerosis	15	2.203 ± 0.303^a	20.628 ± 2.756^a	3.282 ± 0.683^a	1.622 ± 0.418^a
HCC	10	2.577 ± 0.425^a	29.597 ± 6.907^a	3.877 ± 0.625^a	1.830 ± 0.537^a

^aP < 0.05 vs control group. NAFLD: Nonalcoholic fatty liver disease; AFP: Alpha-fetoprotein; HCC: Hepatocellular carcinoma.

Table 2 Dynamic alterations of liver CD44 mRNA and AFP mRNA expression in rat hepatocarcinogenesis

Group	n	Liver CD44 mRNA, × 10⁷/per mg tissues	Liver AFP mRNA, × 10⁸/per mg tissues
Control	12	1.844 ± 0.305	4.859 ± 0.636
NAFLD	24	2.234 ± 0.441	4.150 ± 0.439
Denaturation	17	3.008 ± 0.436^a	5.575 ± 1.672
Precancerosis	15	2.942 ± 0.530^a	6.749 ± 0.949^a
HCC	10	3.593 ±1.554^a	5.731 ± 0.404^a

^aP < 0.05 vs control group. AFP: Alpha-fetoprotein; HCC: Hepatocellular carcinoma; NAFLD: Nonalcoholic fatty liver disease.

Citation: Fang M, Yao M, Yang J, Zheng WJ, Wang L, Yao DF. Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis. World J Gastrointest Oncol 2020; 12(1): 66-76
URL: https://www.wjgnet.com/1948-5204/full/v12/i1/66.htm
DOI: https://dx.doi.org/10.4251/wjgo.v12.i1.66